Stereotaxis, Inc. Common Stock (STXS)
2.4500
+0.2600 (11.87%)
NYSE · Last Trade: Aug 8th, 1:41 PM EDT
Detailed Quote
Previous Close | 2.190 |
---|---|
Open | 2.300 |
Bid | 2.440 |
Ask | 2.450 |
Day's Range | 2.290 - 2.490 |
52 Week Range | 1.540 - 2.716 |
Volume | 652,966 |
Market Cap | 210.70M |
PE Ratio (TTM) | -7.903 |
EPS (TTM) | -0.3 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 635,379 |
Chart
About Stereotaxis, Inc. Common Stock (STXS)
Stereotaxis Inc is a medical device company that specializes in advanced robotic systems for the cardiovascular catheterization market. The company's innovative technologies focus on enhancing the precision and effectiveness of minimally invasive procedures, particularly in the treatment of arrhythmias and other heart conditions. By integrating advanced robotics and navigation systems, Stereotaxis aims to improve the outcomes of electrophysiological procedures, enabling physicians to perform complex interventions with greater safety and efficiency. Their commitment to innovation and patient care positions them as a leader in the evolving landscape of cardiac treatments. Read More
News & Press Releases
Stereotaxis Inc (NYSE:STXS) Q2 2025 earnings beat revenue estimates with $8.8M, narrowing losses to -$0.05 EPS. Stock rose 1.83% post-announcement.
Via Chartmill · August 7, 2025
Stereotaxis shares are moving higher on Wednesday after the company announced it was accepted into the NVIDIA Connect program.
Via Benzinga · March 19, 2025

STXS stock results show that Stereotaxis missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 12, 2024

Via Benzinga · June 18, 2024

STXS stock results show that Stereotaxis met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 13, 2024

Although penny stocks to rebound represent one of the riskiest market categories, there could be some substance here.
Via InvestorPlace · April 19, 2024

These seven penny stocks to buy have the potential to 5X your money by the end of 2024 if the right catalysts unfold.
Via InvestorPlace · April 10, 2024

Although lesser-known ideas present high risks, these cheap stocks under $10 could be intriguing for the calculating speculator.
Via InvestorPlace · March 17, 2024

Via Benzinga · March 4, 2024

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its fourth quarter.
Via Benzinga · March 4, 2024

Via Benzinga · January 12, 2024

The Dow Jones closed lower by around 80 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Via Benzinga · December 6, 2023

Via Benzinga · September 18, 2023

The Dow Jones closed higher by more than 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Via Benzinga · August 29, 2023

Stereotaxis, Inc. (AMEX: STXS) reported Q2 revenues of $7.859 million,
Via Benzinga · August 10, 2023

Gainers Oncorus, Inc. (NASDAQ: ONCR) shares surged 258% to $0.2781.
Via Benzinga · June 16, 2023